Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
After many false starts and canceled projects, Star Wars is finally ready to return to theaters. Lucasfilm announced three new upcoming standalone movies during the opening of Star Wars ...
NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback